Dr. Jane Burns' research focuses on cystic fibrosis microbiology. Her laboratory studies the pathogenesis and treatment of cystic fibrosis (CF) lung infections.
Burns directs the Center for Cystic Fibrosis Microbiology, a Therapeutics Development Network core laboratory that works with investigators and pharmaceutical companies to develop new antibiotics for the treatment of cystic fibrosis.
She also heads the Cystic Fibrosis Isolate Core, which provides CF bacterial isolates to researchers at the University of Washington and other academic institutions. The collection contains thousands of isolates from CF patients and is funded by the National Institutes of Health.
Jane L. Burns, MD, is a principal investigator at Seattle Children's Research Institute and a professor of pediatrics in the Division of Infectious Diseases at the University of Washington. She received an MD from the University of Washington School of Medicine, did her residency at Seattle Children's Hospital and was an infectious disease fellow at Seattle Children's. She has been on the faculty since 1986.